Nitrosamines – EMA-HMA Report on EMRN Response to Impurities in Medicines The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have published a report outlining the European medicines regulatory network’s (EMRN) response to nitrosamine impurities in human medicines. Nitrosamines – EMA-HMA Report on EMRN Response to Impurities in Medicines
CMDh July 2025 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the CMDh meeting held on 22-23 July 2025. CMDh July 2025 Meeting – Report
UK REACH: Rationale for priorities 2025-2026 Defra, and the Scottish and Welsh Governments have set out a rationale for the UK REACH work programme for the 2025-2026 financial year. UK REACH: Rationale for priorities 2025-2026
Consultation on Draft Revised EU Herbal Monographs for Wild Strawberry Leaf, Liquorice Root and Species Diureticae Draft revised EU herbal monographs for Wild Strawberry Leaf, Liquorice Root and Species diureticae have been published for public consultation. Consultation on Draft Revised EU Herbal Monographs for Wild Strawberry Leaf, Liquorice Root and Species Diureticae
Cannabis Sativa Flos – Public Statement from HMPC for Comments The HMPC draft Public statement on Cannabis sativa L., flos has been published for public consultation. Cannabis Sativa Flos – Public Statement from HMPC for Comments
EU-US Trade Deal Agreement – Tariffs Impact On 27 July 2025, the EU and US reached an agreement on a EU-US trade deal, covering import and export tariffs and other trade regulations. EU-US Trade Deal Agreement – Tariffs Impact
CMDh June 2025 Meeting – Minutes The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the minutes from their meeting held on 17-19 June 2025. CMDh June 2025 Meeting – Minutes
EMA HMPC Meeting Report – July 2025 The report from the EMA Committee on Herbal Medicinal Products (HMPC) meeting held on 7-9 July 2025 has been published. EMA HMPC Meeting Report – July 2025
MHRA Performance Data – June 2025 MHRA has published its performance data for June 2025. MHRA Performance Data – June 2025
Final Revised EMA Guideline on the Pharmaceutical Quality of Inhalation and Nasal Medicinal Products EMA has published the final revised Guideline on the pharmaceutical quality of inhalation and nasal medicinal products. The guideline comes into effect on 1 February 2026. Final Revised EMA Guideline on the Pharmaceutical Quality of Inhalation and Nasal Medicinal Products
Update from UK ePI Task Force: Publication of Government’s Life Sciences Sector Plan An update from the UK Electronic Patient Information (ePI) Task Force on the Government’s Life Sciences Sector Plan has been shared. Update from UK ePI Task Force: Publication of Government’s Life Sciences Sector Plan
MHRA Consultation on ICH E20 Guideline on Adaptive Designs For Clinical Trials MHRA has launched a consultation on the International Council for Harmonisation (ICH) E20 Guideline on adaptive designs for clinical trials. The consultation closes at 11:59pm on 30 November 2025. MHRA Consultation on ICH E20 Guideline on Adaptive Designs For Clinical Trials
